Abdominal Surgical Robot segmentation by application delineates distinct procedural domains that collectively drive market revenue. General surgery—including cholecystectomy, hernia repair, and appendectomy—accounts for the largest share, reflecting its high procedure volume and early adoption of robotic assistance; it contributes roughly 35 % of total market value. Gynecological surgery, encompassing hysterectomy and myomectomy, follows with an estimated 25 % share, propelled by demand for precision in pelvic anatomy and reduced postoperative pain. Urological surgery, covering prostatectomy and nephrectomy, represents about 20 % of the market, supported by the need for nerve‑sparing techniques. Colorectal surgery, which involves low anterior resection and colectomy, contributes near 15 % as surgeons seek enhanced visualization in confined spaces. The residual Other category (≈5 %) captures emerging indications such as bariatric and transplant procedures. Each application segment adds incremental revenue through device sales, service contracts, and consumables, and the aggregate defines the overall size of the Abdominal Surgical Robot market.